BLGO
BIOLARGO, INC.
Key Financials
Net Income
$-3692116
↓ 46.0%
Gross Profit
$3.4M
↓ 56.6%
Operating Income
$-14855000
↓ 243.0%
Total Assets
$8.3M
↓ 20.9%
Revenue
$12.2M
↑ 4250.7%
Shareholders' Equity
$4.0M
↓ 54.3%
Total Liabilities
$6.8M
↑ 52.2%
Long-term Debt
$2.1M
↑ 92.7%
Recent SEC Filings
| Form Type | Filed Date | Link |
|---|---|---|
| 4 | 10/2/2026 | View on SEC |
| 4 | 10/2/2026 | View on SEC |
| 4 | 10/2/2026 | View on SEC |
| 4 | 10/2/2026 | View on SEC |
| 4 | 10/2/2026 | View on SEC |
| 4 | 10/2/2026 | View on SEC |
| 8-K/A | 9/14/2026 | View on SEC |
| 8-K | 9/11/2026 | View on SEC |
| 10-Q | 8/14/2026 | View on SEC |
| 4 | 7/7/2026 | View on SEC |
Company Information
| Field | Value |
|---|---|
| Ticker | BLGO |
| Company Name | BIOLARGO, INC. |
| CIK | 880242 |
| Sector | Chemicals & Allied Products |
| Industry | Non-accelerated filer Smaller reporting company |
| Exchange | OTC |
| SIC Code | 2800 |
| SIC Description | Chemicals & Allied Products |
| Entity Type | operating |
| Fiscal Year End | 1231 |
| State of Incorporation | DE |
| Phone | 888 400-2863 |